BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Jan 7 9:18 PM | XIAODONG WANG | Proposed Sale | 125,280 | $180.64 | $22.6M | — | View → |
| Dec 10, 2024 | Dec 10 9:26 PM | XIAODONG WANG | Proposed Sale | 41,760 | $207.62 | $8.7M | — | View → |
| Dec 9, 2024 | Dec 10 2:48 AM | 667, L.P. | Proposed Sale | 86,110 | $187.27 | $16.1M | — | View → |
| Dec 9, 2024 | Dec 10 2:48 AM | Baker Brothers Life Sciences, L.P. | Proposed Sale | 950,907 | $187.27 | $178.1M | — | View → |
| Dec 2, 2024 | Dec 3 2:45 AM | HHLR Advisors, Ltd. (1) | Proposed Sale | 1,372,500 | $215.00 | $295.1M | — | View → |
| Nov 26, 2024 | Nov 26 9:23 PM | XINSHENG LIAO TTEE XIAODONG WANG & XIAYING ZHU FAM TRUST | Proposed Sale | 7,883 | $190.30 | $1.5M | — | View → |
| Nov 26, 2024 | Nov 26 9:23 PM | XIAODONG WANG | Proposed Sale | 40,468 | $190.30 | $7.7M | — | View → |
| Nov 25, 2024 | Nov 25 9:39 PM | PAN-OYLER FOUNDATION | Proposed Sale | 1,969 | $190.51 | $375.1K | — | View → |
| Oct 8, 2024 | Oct 8 8:24 PM | JOHN F OYLER | Proposed Sale | 6,175 | $243.02 | $1.5M | — | View → |
| Oct 8, 2024 | Oct 8 8:23 PM | OYLER INVESTMENT LLC | Proposed Sale | 10,000 | $243.02 | $2.4M | — | View → |
| Sep 30, 2024 | Sep 30 8:27 PM | CHAN LEE | Proposed Sale | 1,202 | $218.42 | $262.5K | — | View → |
| Sep 27, 2024 | Sep 27 8:25 PM | WANG HOLDINGS LLC | Proposed Sale | 5,000 | $212.53 | $1.1M | — | View → |
| Sep 17, 2024 | Sep 17 8:40 PM | XIAOBIN WU | Proposed Sale | 5,000 | $196.45 | $982.3K | — | View → |
| Sep 3, 2024 | Sep 3 9:00 PM | AIJUN WANG | Proposed Sale | 3,160 | $190.08 | $600.7K | — | View → |
| Sep 3, 2024 | Sep 3 8:19 PM | XIAOBIN WU | Proposed Sale | 5,556 | $191.78 | $1.1M | — | View → |
| Aug 27, 2024 | Aug 27 8:30 PM | PAN-OYLER FOUNDATION | Proposed Sale | 1,883 | $199.22 | $375.1K | — | View → |
← Previous
Page 8 of 8
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 403,364(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Option Exercise | 403,364 | — | 806,715(D) | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 1,210,079(D) | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Option Exercise | 34,658 | — | 88,582(D) | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,697 | — | 98,930(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 441,870 | — | 0(D) | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 840,164 | — | 441,870(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 2,165,761 | — | 1,282,034(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,515,241 | — | 1,254,513(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,736,800 | — | 462,866(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 630,760 | — | 1,264,666(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 152,074 | — | 1,895,426(D) | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 8,632 | — | 105,300(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
Page 1 of 2
Next →